Pharmaceuticals Industry in Africa: Database of Importers in Africanaved
The pharmaceuticals industry in Africa is one of the fastest growing sectors of business in Africa. The value of Africa’s pharmaceutical industry is expected to be worth $40 billion to $65 billion by 2020 from just $14.5 billion a decade earlier. This makes Africa a prime market for multinationals and pharmaceutical companies seeking new growth markets as traditional markets stagnate. The rapid growth of the pharmaceutical industry in Africa also augurs well for African patients, who have gained access to medicines previously unavailable in the African markets.
By 2020, prescription drugs are forecast to grow at a compound annual growth rate of 6 percent, generics at 9 percent, over-the-counter medicines at 6 percent, and medical devices at 11 percent. Some of the main factors driving the booming pharmaceutical industry in Africa are:
The Market for Pharmaceuticals in Africa
Africa’s population is growing at a fast pace and changing the dynamics of the pharmaceuticals industry in Africa. It is estimated that by 2025, two-fifths of Africa’s economic growth will come from 30 African cities of two million people or more; 22 of these African cities will have GDP in excess of $20 billion. Cities in Africa have better logistics infrastructure and healthcare facilities, and urban households have more purchasing power and are quicker to adopt modern medicines – thereby making the pharmaceuticals industry in Africa an attractive business sector in the coming years.
Pharmaceuticals Industry in Africa
In the last decade alone, African countries have added 70,000 new hospital beds, 16,000 doctors, and 60,000 nurses. Africa’s healthcare sector is becoming increasingly effective through initiatives such as Mozambique’s switch to specialist nurse anesthetists and South Africa’s use of nurses to initiate antiretroviral drug therapy. The introduction of innovative delivery models is further increasing capacity and providing growth to the pharmaceuticals industry in Africa.
Pharmaceutical Companies in Africa
In order to regulate the rapid growth of the pharmaceuticals industry in Africa, African governments have introduced price controls and import restrictions to encourage domestic drug manufacture; making country-specific labeling mandatory to reduce counterfeiting and parallel imports; and tightening laws on import, wholesale, and retail margins. In the pharma industry, meanwhile, pharmacy chains in Africa are consolidating, horizontal and vertical integration is on the rise, and manufacturing is expanding. A flurry of mergers and acquisitions, joint ventures, strategic alliances, partnerships, and private-equity deals are further extending Africa’s pharmaceuticals market.
Database of Importers of Pharmaceuticals in Africa
The Africa Business Pages has compiled a database of importers of pharmaceuticals for those wanting to export pharmaceuticals to Africa. The database contains list of pharmaceuticals companies in Africa, importers of pharmaceuticals in Africa, companies in Africa engaged in hospital supplies, list of pharmacies in Africa, importers of hospital furniture in Africa as well as wholesalers of pharmaceuticals in Africa.
Pharmaceutical companies wanting to export to Africa will find this database useful in identifying potential business partners in the African markets and contacting them with their business proposal. Many pharmaceutical companies use this resource for email marketing by using the Africa Pharmaceuticals Directory as an email database to reach importers in Africa of various pharmaceuticals.
This database cum importers directory contains corporate information about importers of pharmaceuticals in Africa and also lists pharmacies in Africa, pharmaceutical companies marketing products in the African markets. Information includes company name, addresses, telephone numbers, fax numbers, mobile numbers, emails, links to corporate websites and business classification where applicable. You can also sort the data under different countries in order to target importers of pharmaceuticals in Africa, hospital suppliers in Africa.